Detalhe da pesquisa
1.
Marker-free characterization of full-length transcriptomes of single live circulating tumor cells.
Genome Res
; 33(1): 80-95, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414416
2.
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
N Engl J Med
; 386(10): 942-950, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263519
3.
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Hum Genomics
; 17(1): 66, 2023 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461096
4.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw
; : 1-9, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744306
5.
Potential value of ctDNA monitoring in metastatic HR + /HER2 - breast cancer: longitudinal ctDNA analysis in the phase Ib MONALEESASIA trial.
BMC Med
; 21(1): 306, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580773
6.
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis.
BMC Med
; 20(1): 105, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296300
7.
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.
Breast Cancer Res Treat
; 189(3): 665-676, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553296
8.
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer.
Cancer Sci
; 111(9): 3313-3326, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32619077
9.
Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation.
J Med Genet
; 56(4): 209-219, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530636
10.
Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention.
Br J Cancer
; 120(4): 407-423, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30713340
11.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717303
12.
Patterns of relapse after neoadjuvant chemotherapy in breast cancer: implications for surveillance in clinical practice.
Breast Cancer Res Treat
; 177(1): 197-206, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147984
13.
Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
Breast Cancer Res Treat
; 177(3): 549-559, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270763
14.
Assessment of PARP4 as a candidate breast cancer susceptibility gene.
Breast Cancer Res Treat
; 177(1): 145-153, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31119570
15.
Correction: Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
Hum Genomics
; 17(1): 74, 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580755
16.
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer.
Future Oncol
; 15(21): 2489-2501, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140297
17.
Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Breast Cancer Res Treat
; 168(3): 713-721, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313215
18.
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Breast Cancer Res Treat
; 171(3): 719-735, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926297
19.
Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.
Psychooncology
; 27(4): 1185-1192, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315963
20.
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
Br J Clin Pharmacol
; 81(6): 1142-52, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799162